Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes

OBJECTIVE: Thiazolidinediones reduce hepatic steatosis and increase HDL cholesterol levels. In mice with human-like lipoprotein metabolism (APOE*3-Leiden.CETP transgenic mice), a decrease in hepatic triglyceride content is associated with a decrease in plasma cholesteryl ester transfer protein (CETP...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Jonker, Jacqueline T., Wang, Yanan, de Haan, Willeke, Diamant, Michaela, Rijzewijk, Luuk J., van der Meer, Rutger W., Lamb, Hildo J., Tamsma, Jouke T., de Roos, Albert, Romijn, Johannes A., Rensen, Patrick C.N., Smit, Johannes W.A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Diabetes Association 2010
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2890371/
https://ncbi.nlm.nih.gov/pubmed/20150294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-1935
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia